Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 331

1.

Feasibility of a combined strategy of HPV vaccination and screening in Mexico: the FASTER-Tlalpan Study experience.

León-Maldonado L, Cabral A, Brown B, Ryan GW, Maldonado A, Salmerón J, Allen-Leigh B, Lazcano-Ponce E; FASTER Study Group.

Hum Vaccin Immunother. 2019 Jun 11. doi: 10.1080/21645515.2019.1619401. [Epub ahead of print]

PMID:
31184976
2.

HPV-specific antibodies at the oral cavity up to 30 months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men.

Parker KH, Kemp TJ, Isaacs-Soriano K, Abrahamsen M, Pan Y, Lazcano-Ponce E, Salmeron J, Pinto LA, Giuliano AR.

Vaccine. 2019 May 9;37(21):2864-2869. doi: 10.1016/j.vaccine.2019.03.064. Epub 2019 Apr 17.

PMID:
31005426
3.

The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study.

Nyitray AG, Peng F, Day RS, Carvalho Da Silva RJ, Baggio ML, Salmerón J, Quiterio M, Abrahamsen M, Lazcano-Ponce E, Villa LL, Giuliano AR.

Hum Vaccin Immunother. 2019 Mar 21:1-9. doi: 10.1080/21645515.2019.1593083. [Epub ahead of print]

PMID:
30897017
4.

Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study.

Hurtado-Salgado E, Ortiz-Panozo E, Salmerón J, Saavedra-Lara N, Kuri-Morales P, Pesqueira-Villegas E, Luna-Gordillo R, Franco EL, Lazcano-Ponce E.

Salud Publica Mex. 2018 Nov-Dic;60(6):722-733. doi: 10.21149/9891.

PMID:
30699277
5.

Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study.

Lazcano-Ponce E, Salmerón J, González A, Allen-Leigh B, León-Maldonado L, Magis C, Aranda-Flores C, Conde-González C, Portillo-Romero AJ, Yunes-Díaz E, Rivera-Rivera L, Vargas G, Nyitray AG, Giuliano AR.

Salud Publica Mex. 2018 Nov-Dic;60(6):703-712. doi: 10.21149/10034.

PMID:
30699275
6.

The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules.

Lazcano-Ponce E, Carnalla-Cortés M, Barrientos-Gutiérrez T, Torres-Ibarra L, Cruz-Valdez A, Salmerón J, Hernández-Ávila M.

Salud Publica Mex. 2018 Nov-Dic;60(6):666-673. doi: 10.21149/10183.

PMID:
30699272
7.

HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV.

Portillo-Romero AJ, León-Maldonado L, Allen-Leigh B, Brown B, Magis C, García-Fuentes NB, Salmerón J, Hurtado E, Torres-Ibarra L, Rivera-Paredez B, Hernández-López R, Yunes-Díaz E, Lazcano-Ponce E.

Salud Publica Mex. 2018 Nov-Dic;60(6):658-665. doi: 10.21149/10182.

PMID:
30699271
8.

Prevalence and incidence of anal human papillomavirus infection in Mexican men: Need for universal prevention policies.

Posso H, León-Maldonado L, Allen-Leigh B, Salmerón J, Quiterio M, Giuliano AR, Sudenga SL, Nyitray AG, Torres BN, Abrahamsen M, Lazcano-Ponce E.

Salud Publica Mex. 2018 Nov-Dic;60(6):645-652. doi: 10.21149/8454.

PMID:
30699269
9.

Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study.

Lazcano-Ponce E, Sudenga SL, Torres BN, Stoler M, León-Maldonado L, Allen-Leigh B, Posso H, Quiterio M, Hernández-Nevarez MDP, Salmerón J, Giuliano AR.

Salud Publica Mex. 2018 Nov-Dic;60(6):633-644. doi: 10.21149/8461.

PMID:
30699268
10.

Incidence, psychosocial burden, and economic impact of genital warts in Mexico.

Domenech-Viñolas M, León-Maldonado L, Ramírez-Palacios P, Flores YN, Granados-García V, Brown B, Corona E, Liu S, Lazcano-Ponce E, Salmerón J.

Salud Publica Mex. 2018 Nov-Dic;60(6):624-632. doi: 10.21149/10008.

PMID:
30699267
11.

La nueva oleada de la investigación en salud pública: de la evidencia a la política.

Lazcano-Ponce E.

Salud Publica Mex. 2018 Sep-Oct;60(5):498-499. doi: 10.21149/10022. Spanish. No abstract available.

PMID:
30550110
12.

Genital Wart Recurrence Among Men Residing in Brazil, Mexico, and the United States.

Giuliano AR, Sirak B, Abrahamsen M, Silva RJC, Baggio ML, Galan L, Cintra RC, Lazcano-Ponce E, Villa LL.

J Infect Dis. 2019 Feb 15;219(5):703-710. doi: 10.1093/infdis/jiy533.

PMID:
30388232
13.

Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination.

Lazcano-Ponce E, Torres-Ibarra L, Cruz-Valdez A, Salmerón J, Barrientos-Gutiérrez T, Prado-Galbarro J, Stanley M, Muñoz N, Herrero R, Hernández-Ávila M.

J Infect Dis. 2019 Jan 1;219(1):41-49. doi: 10.1093/infdis/jiy465.

14.

Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact.

Gilca V, Salmerón-Castro J, Sauvageau C, Ogilvie G, Landry M, Naus M, Lazcano-Ponce E.

Vaccine. 2018 Aug 6;36(32 Pt A):4800-4805. doi: 10.1016/j.vaccine.2018.02.004. Epub 2018 Jun 7.

15.

Providers perspective and geographic and institutional factors associated with family planning counseling.

de la Vara-Salazar E, Suárez-López L, Rivera L, Lazcano-Ponce E.

Sex Reprod Healthc. 2018 Jun;16:33-38. doi: 10.1016/j.srhc.2018.01.005. Epub 2018 Jan 31.

PMID:
29804772
16.

Recurrence of Genital Infections With 9 Human Papillomavirus (HPV) Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) Among Men in the HPV Infection in Men (HIM) Study.

Pamnani SJ, Sudenga SL, Rollison DE, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Huang Y, Borenstein A, Giuliano AR.

J Infect Dis. 2018 Sep 8;218(8):1219-1227. doi: 10.1093/infdis/jiy300.

PMID:
29800222
17.

Correction: Expected population weight and diabetes impact of the 1-peso-per-litre tax to sugar sweetened beverages in Mexico.

Barrientos-Gutierrez T, Zepeda-Tello R, Rodrigues ER, Colchero MA, Rojas-Martínez R, Lazcano-Ponce E, Hernández-Ávila M, Rivera-Dommarco J, Meza R.

PLoS One. 2018 Jan 11;13(1):e0191383. doi: 10.1371/journal.pone.0191383. eCollection 2018.

18.

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.

Ruiz-Sternberg ÁM, Moreira ED Jr, Restrepo JA, Lazcano-Ponce E, Cabello R, Silva A, Andrade R, Revollo F, Uscanga S, Victoria A, Guevara AM, Luna J, Plata M, Dominguez CN, Fedrizzi E, Suarez E, Reina JC, Ellison MC, Moeller E, Ritter M, Shields C, Cashat M, Perez G, Luxembourg A.

Papillomavirus Res. 2018 Jun;5:63-74. doi: 10.1016/j.pvr.2017.12.004. Epub 2017 Dec 19.

19.

Real time PCR to evaluate HSV-2 shedding from anal and genital samples among men who have sex with men, living with HIV.

Vergara-Ortega DN, Sevilla-Reyes EE, Herrera-Ortiz A, Torres-Ibarra L, Salmerón J, Lazcano-Ponce E, Sánchez-Alemán MA.

J Med Virol. 2018 Apr;90(4):745-752. doi: 10.1002/jmv.25003. Epub 2018 Jan 18.

PMID:
29236293
20.

Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study.

Ibarra-González I, Rodríguez-Valentín R, Lazcano-Ponce E, Vela-Amieva M.

Salud Publica Mex. 2017 Jul-Aug;59(4):423-428. doi: 10.21149/8668.

PMID:
29211263
21.

Prevalence of functioning difficulties and disability in Mexican adolescent women and their populational characteristics.

Allen-Leigh B, Hubert C, de Castro F, Villalobos A, Rojas R, Romero M, Barrientos-Gutiérrez T, Katz G, Lazcano-Ponce E.

Salud Publica Mex. 2017 Jul-Aug;59(4):389-399. doi: 10.21149/8486.

PMID:
29211259
22.

Child labor and severe functioning difficulties and disability in Mexican children and adolescents 5-17 years of age.

Villalobos A, de Castro F, Rojas R, Allen-Leigh B, Hubert C, Avendaño-Badillo D, Romero M, Vázquez-García A, Barrientos-Gutiérrez T, Lazcano-Ponce E.

Salud Publica Mex. 2017 Jul-Aug;59(4):380-388. doi: 10.21149/8483.

PMID:
29211258
23.

Population profiles associated with severe functional difficulties and disability among 5-17 years-old children in México.

Braverman-Bronstein A, Barrientos-Gutiérrez T, de Castro F, Lazcano-Ponce E, Rojas-Martínez R, Terán V.

Salud Publica Mex. 2017 Jul-Aug;59(4):370-379. doi: 10.21149/8494.

PMID:
29211257
24.

Population profiles associated with severe functioning difficulties and disability among two to four years old children in Mexico.

Rojas-Martínez R, de Castro F, Villalobos A, Romero M, Allen B, Hubert C, Barrientos-Gutiérrez T, Lazcano-Ponce E.

Salud Publica Mex. 2017 Jul-Aug;59(4):361-369. doi: 10.21149/8485.

PMID:
29211256
25.

[Mental health in the populational field: the utopia of social psychiatry in low income countries].

Katz G, Lazcano-Ponce E, Madrigal E.

Salud Publica Mex. 2017 Jul-Aug;59(4):351-353. doi: 10.21149/8860. Spanish. No abstract available.

PMID:
29211254
26.

Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity.

Ranjeva SL, Baskerville EB, Dukic V, Villa LL, Lazcano-Ponce E, Giuliano AR, Dwyer G, Cobey S.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13573-13578. doi: 10.1073/pnas.1714712114. Epub 2017 Dec 5.

27.

Cutaneous HPV and alpha-mucosal 9-valent HPV sero-status associations.

Rahman S, Giuliano AR, Rollison DE, Pawlita M, Waterboer T, Villa LL, Lazcano Ponce E.

Papillomavirus Res. 2017 Dec;4:54-57. doi: 10.1016/j.pvr.2017.08.001. Epub 2017 Aug 2.

28.

4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years.

Ferris DG, Samakoses R, Block SL, Lazcano-Ponce E, Restrepo JA, Mehlsen J, Chatterjee A, Iversen OE, Joshi A, Chu JL, Krick AL, Saah A, Das R.

Pediatrics. 2017 Dec;140(6). pii: e20163947. doi: 10.1542/peds.2016-3947.

29.

Acquisition, Persistence, and Clearance of Human Papillomavirus Infection Among Male Virgins Residing in Brazil, Mexico, and the United States.

Liu Z, Nyitray AG, Hwang LY, Swartz MD, Abrahamsen M, Lazcano-Ponce E, Villa LL, Giuliano AR.

J Infect Dis. 2018 Feb 14;217(5):767-776. doi: 10.1093/infdis/jix588.

30.

Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.

Allen-Leigh B, Uribe-Zúñiga P, León-Maldonado L, Brown BJ, Lörincz A, Salmeron J, Lazcano-Ponce E.

BMC Cancer. 2017 Nov 9;17(1):734. doi: 10.1186/s12885-017-3723-5.

31.

HPV-11 variability, persistence and progression to genital warts in men: the HIM study.

Flores-Díaz E, Sereday KA, Ferreira S, Sirak B, Sobrinho JS, Baggio ML, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR, Villa LL, Sichero L; The HIM Study Group.

J Gen Virol. 2017 Sep;98(9):2339-2342. doi: 10.1099/jgv.0.000896. Epub 2017 Aug 15.

PMID:
28809141
32.

Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study.

Nunes EM, López RVM, Sudenga SL, Gheit T, Tommasino M, Baggio ML, Ferreira S, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR, Villa LL, Sichero L; HIM Study group.

Virology. 2017 Oct;510:55-59. doi: 10.1016/j.virol.2017.07.006. Epub 2017 Jul 11.

33.

Expected population weight and diabetes impact of the 1-peso-per-litre tax to sugar sweetened beverages in Mexico.

Barrientos-Gutierrez T, Zepeda-Tello R, Rodrigues ER, Colchero MA, Rojas-Martínez R, Lazcano-Ponce E, Hernández-Ávila M, Rivera-Dommarco J, Meza R.

PLoS One. 2017 May 17;12(5):e0176336. doi: 10.1371/journal.pone.0176336. eCollection 2017. Erratum in: PLoS One. 2018 Jan 11;13(1):e0191383.

34.

Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States.

Sudenga SL, Torres BN, Silva R, Villa LL, Lazcano-Ponce E, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1043-1052. doi: 10.1158/1055-9965.EPI-17-0040. Epub 2017 Apr 26.

35.

[Unhealthy behavior associated with the development of high blood pressure in adolescents].

Sánchez-Zamorano LM, Burguete-García AI, Flores-Sánchez G, Salmerón-Castro J, Lazcano-Ponce EC, Diaz-Benitez CE.

Cad Saude Publica. 2017 Apr 3;33(3):e00017616. doi: 10.1590/0102-311X00017616. Spanish.

36.

Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States.

Sudenga SL, Nyitray AG, Torres BN, Silva R, Villa L, Lazcano-Ponce E, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR.

J Infect. 2017 Jul;75(1):35-47. doi: 10.1016/j.jinf.2017.03.010. Epub 2017 Mar 28.

PMID:
28363585
37.

The intellectual developmental disorders Mexico study: situational diagnosis, burden, genomics and intervention proposal.

Lazcano-Ponce E, Katz G, Rodríguez-Valentín R, Castro F, Allen-Leigh B, Márquez-Caraveo ME, Ramírez-García MÁ, Arroyo-García E, Medina-Mora ME, Ángeles G, Urquieta-Salomón JE, Salvador-Carulla L.

Salud Publica Mex. 2016 Nov-Dec;58(6):694-707. doi: 10.21149/spm.v58i6.8267.

PMID:
28225946
38.

HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study.

Flores-Díaz E, Sereday KA, Ferreira S, Sirak B, Sobrinho JS, Baggio ML, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR, Villa LL, Sichero L; HIM Study group.

J Infect Dis. 2017 Feb 15;215(4):559-565. doi: 10.1093/infdis/jiw600.

39.

Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.

Rahman S, Pierce Campbell CM, Rollison DE, Wang W, Waterboer T, Michel A, Pawlita M, Villa LL, Lazcano Ponce E, Borenstein AR, Giuliano AR.

PLoS One. 2016 Nov 30;11(11):e0167173. doi: 10.1371/journal.pone.0167173. eCollection 2016.

40.

Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study.

Rahman S, Pierce Campbell CM, Waterboer T, Rollison DE, Ingles DJ, Torres BN, Michel A, Sudenga SL, Pawlita M, Villa LL, Lazcano Ponce E, Borenstein AR, Wang W, Giuliano AR.

J Gen Virol. 2016 Dec;97(12):3291-3301. doi: 10.1099/jgv.0.000620. Epub 2016 Oct 6.

41.

Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.

Rahman S, Rollison DE, Pierce Campbell CM, Waterboer T, Michel A, Pawlita M, Villa LL, Lazcano Ponce E, Wang W, Borenstein AR, Giuliano AR.

PLoS One. 2016 Nov 28;11(11):e0167174. doi: 10.1371/journal.pone.0167174. eCollection 2016.

42.

Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study.

Sudenga SL, Torres BN, Fulp WJ, Silva R, Villa LL, Lazcano-Ponce E, Ingles DJ, Stoler M, Messina JL, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR.

Int J Cancer. 2017 Jan 15;140(2):337-345. doi: 10.1002/ijc.30452. Epub 2016 Oct 20.

43.

Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample.

Taylor S, Lopez P, Weckx L, Borja-Tabora C, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Angel Rodriguez Weber M, Mascareñas de Los Santos A, Tinoco JC, Safadi MA, Lim FS, Hernandez-de Mezerville M, Faingezicht I, Cruz-Valdez A, Feng Y, Li P, Durviaux S, Haars G, Roy-Ghanta S, Vaughn DW, Nolan T.

J Infect. 2017 Jan;74(1):29-41. doi: 10.1016/j.jinf.2016.09.003. Epub 2016 Sep 22.

PMID:
27667752
44.

Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico.

Rudolph SE, Lorincz A, Wheeler CM, Gravitt P, Lazcano-Ponce E, Torres-Ibarra L, León-Maldonado L, Ramírez P, Rivera B, Hernández R, Franco EL, Cuzick J, Méndez-Hernández P, Salmerón J; FRIDA Study Group.

BMC Infect Dis. 2016 Sep 1;16:461. doi: 10.1186/s12879-016-1782-x.

45.

Effect of care-delivery delay on the survival of Mexican women with breast cancer.

Ángeles-Llerenas A, Torres-Mejía G, Lazcano-Ponce E, Uscanga-Sánchez S, Mainero-Ratchelous F, Hernández-Ávila JE, Morales-Carmona E, Hernández-Ávila M.

Salud Publica Mex. 2016 Apr;58(2):237-50.

PMID:
27557382
46.

HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico.

Salmerón J, Torres-Ibarra L, Bosch FX, Cuzick J, Lörincz A, Wheeler CM, Castle PE, Robles C, Lazcano-Ponce E.

Salud Publica Mex. 2016 Apr;58(2):211-9.

PMID:
27557379
47.

Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study.

Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, Rivera B, Ramírez P, Mendiola-Pastrana I, Rudolph SE, León-Maldonado L, Hernández R, Barrios E, Gravitt P, Moscicki AB, Schmeler KM, Flores YN, Méndez-Hernández P, Salmerón J; FRIDA Study Group.

Salud Publica Mex. 2016 Apr;58(2):197-210.

PMID:
27557378
48.

Prostate cancer mortality according to marginalization status in Mexican states from 1980 to 2013.

Torres-Sánchez LE, Espinoza-Giacinto R, Rojas-Martínez R, Escamilla-Nuñez C, Vázquez-Salas RA, Campuzano JC, Lazcano-Ponce E.

Salud Publica Mex. 2016 Apr;58(2):179-86.

PMID:
27557376
49.

Cancer burden in Mexico: urgent challenges to be met.

Lazcano-Ponce E, Mohar-Betancourt A, Meneses-García A, Hernández-Ávila M.

Salud Publica Mex. 2016 Apr;58(2):101-3. No abstract available.

PMID:
27557368
50.

Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study.

Pamnani SJ, Sudenga SL, Viscidi R, Rollison DE, Torres BN, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Salmeron J, Quiterio M, Huang Y, Borenstein A, Giuliano AR.

Cancer Res. 2016 Oct 15;76(20):6066-6075. Epub 2016 Aug 17.

Supplemental Content

Loading ...
Support Center